arrow
M

Markus G. Manz

University Hospital Zurich
H指数:79
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improved multistate survival in younger AML patients over time

年轻AML患者随时间推移的多状态生存改善

2026-11-030
OA
Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable‐ and intermediate‐risk patients with AML: A comparative analysis of HOVON–SAKK–Nordic trials

自体干细胞移植与巩固化疗作为新诊断的AML低危和中危患者的缓解后治疗:HOVON–SAKK–Nordic试验的比较分析

2026-08-210
OAAI
A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma

荧光素偶联的生长抑素受体拮抗剂适配体,用于脑膜瘤的嵌合抗原受体T细胞疗法

2026-07-210
OA
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy

卵巢癌肿瘤谱分析资源:化疗驱动的异质性及个性化治疗策略的洞见

2026-07-130
OAAI
Class 3 MAP2K1 mutations are associated with frequent relapse and multiple treatment lines in multi-system Langerhans cell histiocytosis

III类MAP2K1突变与多系统朗格汉斯细胞组织细胞增多症的频繁复发和多线治疗相关

2026-06-170
OAAI
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies

高危MDS患者经强化疗后可测量残留疾病的预后价值:HOVON-SAKK研究

2026-05-210
OAAI
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis

靶向CD117的CAR T细胞在先进系统性肥大细胞增多症的临床前模型中有效清除肥大细胞

Leukemia
IF13.4
2026-05-070
OAAI
MDS/AML AND AML WITH MYELODYSPLASIA-RELATED GENE MUTATIONS: CLINICAL AND MOLECULAR SIMILARITIES

MDS/AML和AML伴骨髓增生异常相关基因突变: 临床和分子相似性

2026-01-160
OAAI
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients

高强度治疗患者中急性髓系白血病干细胞定量测定的不同特征。Haematologica

2025-12-012
OA
Association between hemoglobin levels and mild cognitive impairment in generally healthy European community-dwelling older adults: a three-year prospective analysis of the DO-HEALTH trial

欧洲社区居住的健康老年人血红蛋白水平与轻度认知障碍的关联:DO-HEALTH试验的三年度前瞻性分析

2025-11-130
OAAI
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial

年龄适应化疗和微小残留病导向移植治疗Ph阴性急性淋巴细胞白血病——GRAALL-2014试验

Blood
IF23.1
2025-10-280
PRE
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

急性髓系白血病中的计算性微小残留病评估:一项在HOVON-SAKK-132试验中的回顾性验证

Leukemia
IF13.4
2025-09-030
OAAI
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma

出版者更正:多组学肿瘤分析在指导黑色素瘤治疗中的可行性

2025-08-010
OAAI